Replies to Post #2033 onEnanta Pharmaceuticals Inc (ENTA)

Replies to post #2033 on Enanta Pharmaceuticals Inc (ENTA)

Replies to #2033 on Enanta Pharmaceuticals Inc (ENTA)

08/31/21 9:40 PM

#2034 RE: DewDiligence #2033

Addendum: ENTA is sufficiently well funded to execute the business plan outlined in #msg-165690818.

02/16/22 7:01 PM

#2173 RE: DewDiligence #2033

ENTA’s phase-2a RSV trial published in NEJM:

https://www.nejm.org/doi/full/10.1056/NEJMoa2108903